SFX by Ex Libris Inc.

Title:	Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma
Source:	Nature Genetics [1061-4036] Jones, David T W yr:2013

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Mason, Robert P. "Glutathione peroxidase activity is neuroprotective in models of Huntington's disease." Nature Genetics 45.10 (2013): 1249-1254.
description	2.	Papillon Cavanagh, S. "Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma." Nature Genetics 46.5 (2014): 462-6.
description	3.	Stupp, R. "Molecular neuro-oncology in clinical practice: a new horizon." Lancet oncology 14.9 (2013): 370-9.
description	4.	Chen, Y-H H. "The molecular and cell biology of pediatric low-grade gliomas." Oncogene 33.16 (2013): 2019-2026.
description	5.	Rodriguez, Erika F. "PI3K/AKT pathway alterations are associated with clinically aggressive and histologically anaplastic subsets of pilocytic astrocytoma." Acta neuropathologica 121.3 (2011): 407-420.
description	6.	Olar, A. "Using the Molecular Classification of Glioblastoma to Inform Personalized Treatment." The Journal of pathology 232.2 (2013): 165-177.
description	7.	Kilday, E. "Targeted therapy in pediatric low-grade glioma." Current neurology and neuroscience reports 14.4 (2014): 441-.
description	8.	Avery, Robert A. "Visual acuity in children with low grade gliomas of the visual pathway: implications for patient care and clinical research." Journal of neuro-oncology 110.1 (2012): 1-7.
description	9.	Schwartzentruber, J. "Driver mutations in histone H3. 3 and chromatin remodelling genes in paediatric glioblastoma." Nature 482.7384 (2012): 226-231.
description	10.	Sturm, D. "Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma." Cancer cell 22.4 (2012): 425-437.
description	11.	Limand, K. "Focal Malformations of Cortical Development: New Vistas for Molecular Pathogenesis." Neuroscience 252 (2013): 262-76.
description	12.	Gessi, M. "H3.3 G34R mutations in pediatric primitive neuroectodermal tumors of central nervous system (CNS-PNET) and pediatric glioblastomas: possible diagnostic and therapeutic implications?" Journal of neuro-oncology 112.1 (2013): 67-72.
description	13.	Lin, Y. "Enhancement of brain-type creatine kinase activity ameliorates neuronal deficits in Huntington's disease." Biochimica et biophysica acta 1832.6 (2013): 742-753.
description	14.	Fontebasso, Adam M. "Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas." Acta neuropathologica 125.5 (2013): 659-669.
description	15.	Ohgaki, H. "The Definition of Primary and Secondary Glioblastoma." Clinical cancer research 19.4 (2012): 764-772.
description	16.	Armakola, M. "Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models." Nature Genetics 44.12 (2012): 1302-1309.
description	17.	Giltaire, S. "HB‐EGF synthesis and release induced by cholesterol depletion of human epidermal keratinocytes is controlled by extracellular atp and involves both p38 and ERK1/2 signaling pathways." Journal of cellular physiology 226.6 (2011): 1651-1659.
description	18.	Gutmann, D H. "Parent-of-origin in individuals with familial neurofibromatosis type 1 and optic pathway gliomas." Familial Cancer 11.4 (2012): 653-656.
description	19.	Bellenguez, C. "Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke." Nature Genetics 44.3 (2012): 328-333.
description	20.	Shirendeb, Ulziibat P. "Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease." Human molecular genetics 21.2 (2012): 406-420.